SCHEMBL9811477

SCHEMBL9811477

O=P(O)(O)C(O)(CCN1CCC(c2cccnc2)CC1)P(=O)(O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FDPS P14324 3/20 0.49
BTN3A1 O00481 1/20 0.45
PDE3A Q14432 1/20 0.45
CYP11B2 P19099 1/20 0.43
CHRNA7 P36544 3/20 0.41
CHRNB2 P17787 3/20 0.41
CHRNA4 P43681 3/20 0.41
ALDH1A1 P00352 2/20 0.41
CHRNB4 P30926 2/20 0.41
CHRNA3 P32297 2/20 0.41
CHRNA2 Q15822 2/20 0.41
LMNA P02545 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
HTR3E A5X5Y0 1/20 0.41
PSIP1 O75475 1/20 0.41
TRPA1 O75762 1/20 0.41
HTR3B O95264 1/20 0.41
CHRNA1 P02708 1/20 0.41
CHRNG P07510 1/20 0.41
MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9811461 0.85 HRH3 (0.46) FDPSSLC18A3KCNA3
SCHEMBL9298267 0.85 SLC18A3 (0.57) SLC18A3KCNA3
SCHEMBL9811498 0.79 ALDH1A1 (0.53) ALDH1A1LMNAMAPTSLC18A3KCNA3
SCHEMBL9811543 0.79 DRD4 (0.49) SLC18A3CCR5
SCHEMBL6221175 0.78 SLC18A3 (0.55) SLC18A3KCNA3
SCHEMBL9811522 0.78 DRD2 (0.48) SLC18A3
SCHEMBL9811433 0.78 DRD2 (0.46) SLC18A3KCNA3
SCHEMBL6223991 0.78 DRD2 (0.57)
SCHEMBL9811541 0.77 DRD4 (0.50) FDPSALDH1A1
SCHEMBL9811545 0.76 SIGMAR1 (0.56) SLC18A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0272208-B1 AROMATICALLY SUBSTITUTED AZACYCLO-ALKYLALKANEDIPHOSPHONIC ACIDS CIBA-GEIGY AG (CH) 1991-06-12 EP disclosed
US-4871720-A Aromatically substituted azacycloalkyl-alkanediphosphonic acids useful for the treatment of illnesses that can be attributed to calcium metabolism disorders CIBA-GEIGY CORPORATION (US) 1989-10-03 US disclosed
EP-0272208-A1 Aromatically substituted azacyclo-alkylalkanediphosphonic acids CIBA-GEIGY AG (CH) 1988-06-22 EP disclosed